NOUVEAL & MAELA, A COMMITTED ALLIANCE FOR HEALTH
The partner of the
connected and personalized care pathway
Through a digital platform
for all
caregivers, patients, territories, follow-ups, establishments

NOUVEAL & MAELA, A COMMITTED ALLIANCE FOR HEALTH
The partner of the
connected and personalized care pathway
Through a digital platform
for all
caregivers, patients, territories, follow-ups, establishments

Simplify the pathways of health, care and life
Increase the care's efficiency
Caring for the patient in his environment
Simplify the pathways of health, care and life
Increase the care's efficiency
Caring for the patient in his environment
An answer to
job's issues

An ally to meet
the challenges of tomorrow
An answer to
job's issues

An ally to meet
the challenges of tomorrow
Our quality and safety commitments
Aware of the regulatory and ethical constraints incumbent on medical practice, offering you solutions that meet safety and quality requirements is a priority for us.

Class 1
medical device
Our solutions are recognized as a medical device complying with the health and safety requirements set out in European legislation.

ISO 13485
certification
Nouveal has successfully embarked on an ISO 13485 certification process attesting to compliance with the requirements imposed on medical devices.

ENS partner
As part of the ministerial health roadmap, Nouveal is one of the actors selected to participate in the development of eligibility criteria for solutions that will be included in the ENS catalog.

INS
compliance
Core project of the digital health roadmap, our solutions integrate the INS to secure patient identification and the sharing of health data between professionals.
Usage rate
Unscheduled care avoided
Professionals recommend Nouveal to their colleagues
Patients surveyed report reduced stress
Usage rate
Unscheduled care avoided
Professionals recommend Nouveal to their colleagues
Patients surveyed report reduced stress
CLIENTS
They trust us
Already more than 230 establishments have chosen our solutions for the follow-up of their patients, and you?